Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects

Background. Excess circulating thyroid hormones are associated with increased cardiac atrial natriuretic peptide (ANP) secretion but the exact mechanisms involved have not been fully elucidated in vivo. Methods. To examine whether thyroid hormone regulation of ANP secretion is the result of a direct...

Full description

Bibliographic Details
Main Authors: Gregory Giamouzis, Dimitrios Pappas, Nikolaos Simeonidis, Evangelos Stathogiannis, Filippos Triposkiadis, George N. Koukoulis
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.4061/2011/381865
id doaj-3ea9223f75294050be30cc47f1f36723
record_format Article
spelling doaj-3ea9223f75294050be30cc47f1f367232020-11-24T22:37:44ZengHindawi LimitedCardiology Research and Practice2090-05972011-01-01201110.4061/2011/381865381865Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy SubjectsGregory Giamouzis0Dimitrios Pappas1Nikolaos Simeonidis2Evangelos Stathogiannis3Filippos Triposkiadis4George N. Koukoulis5Department of Cardiology and the Heart Failure Clinic, University Hospital of Larissa, University of Thessaly School of Medicine, Larissa, GreeceNuclear Medicine Unit, Hellenic Airforce (HAF) and Veterans Administration (VA) General Hospital, Athens, GreeceDepartment of Internal Medicine, Hellenic Airforce (HAF) and Veterans Administration (VA) General Hospital, Athens, GreeceDepartment of Internal Medicine, Hellenic Airforce (HAF) and Veterans Administration (VA) General Hospital, Athens, GreeceDepartment of Cardiology and the Heart Failure Clinic, University Hospital of Larissa, University of Thessaly School of Medicine, Larissa, GreeceDepartment of Endocrinology and Metabolic Diseases, University Hospital of Larissa, University of Thessaly School of Medicine, 41110 Larissa, GreeceBackground. Excess circulating thyroid hormones are associated with increased cardiac atrial natriuretic peptide (ANP) secretion but the exact mechanisms involved have not been fully elucidated in vivo. Methods. To examine whether thyroid hormone regulation of ANP secretion is the result of a direct action on the myocardium and/or of an indirect action through alterations in the peripheral circulation, plasma ANP levels (baseline and volume expansion-induced) were evaluated in 14 healthy men, before and after triiodothyronine (T3) administration. Results. T3 administration was followed by a significant increase in serum T3 levels and a significant decrease in serum TSH levels, without significantly affecting ANP levels. Systemic vascular resistance, plasma rennin activity (PRA), and aldosterone (ALDO) levels, as well as indices of left atrial function, were not significantly altered, despite a significant increase in cardiac output. Plasma volume expansion, induced by a 1500 ml normal saline (NSal) infusion, both before and after T3 administration, was followed by a significant decrease in PRA and ALDO and a significant increase in plasma ANP levels, without significantly affecting the mean blood pressure (BP) and heart rate (HR) in each study period. The NSal-induced response, measured as the integrated area under the curve corrected for baseline values (-AUC), was not different after T3 administration for ANP, ALDO, PRA, HR, and mean BP. Conclusion. In vivo thyroid hormone-induced myocardial ANP secretion is the result of an indirect action mainly through hemodynamic changes that increase atrial stretch.http://dx.doi.org/10.4061/2011/381865
collection DOAJ
language English
format Article
sources DOAJ
author Gregory Giamouzis
Dimitrios Pappas
Nikolaos Simeonidis
Evangelos Stathogiannis
Filippos Triposkiadis
George N. Koukoulis
spellingShingle Gregory Giamouzis
Dimitrios Pappas
Nikolaos Simeonidis
Evangelos Stathogiannis
Filippos Triposkiadis
George N. Koukoulis
Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
Cardiology Research and Practice
author_facet Gregory Giamouzis
Dimitrios Pappas
Nikolaos Simeonidis
Evangelos Stathogiannis
Filippos Triposkiadis
George N. Koukoulis
author_sort Gregory Giamouzis
title Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
title_short Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
title_full Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
title_fullStr Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
title_full_unstemmed Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
title_sort acute experimental hyperthyroidism does not affect basal and volume-induced atrial natriuretic peptide secretion in healthy subjects
publisher Hindawi Limited
series Cardiology Research and Practice
issn 2090-0597
publishDate 2011-01-01
description Background. Excess circulating thyroid hormones are associated with increased cardiac atrial natriuretic peptide (ANP) secretion but the exact mechanisms involved have not been fully elucidated in vivo. Methods. To examine whether thyroid hormone regulation of ANP secretion is the result of a direct action on the myocardium and/or of an indirect action through alterations in the peripheral circulation, plasma ANP levels (baseline and volume expansion-induced) were evaluated in 14 healthy men, before and after triiodothyronine (T3) administration. Results. T3 administration was followed by a significant increase in serum T3 levels and a significant decrease in serum TSH levels, without significantly affecting ANP levels. Systemic vascular resistance, plasma rennin activity (PRA), and aldosterone (ALDO) levels, as well as indices of left atrial function, were not significantly altered, despite a significant increase in cardiac output. Plasma volume expansion, induced by a 1500 ml normal saline (NSal) infusion, both before and after T3 administration, was followed by a significant decrease in PRA and ALDO and a significant increase in plasma ANP levels, without significantly affecting the mean blood pressure (BP) and heart rate (HR) in each study period. The NSal-induced response, measured as the integrated area under the curve corrected for baseline values (-AUC), was not different after T3 administration for ANP, ALDO, PRA, HR, and mean BP. Conclusion. In vivo thyroid hormone-induced myocardial ANP secretion is the result of an indirect action mainly through hemodynamic changes that increase atrial stretch.
url http://dx.doi.org/10.4061/2011/381865
work_keys_str_mv AT gregorygiamouzis acuteexperimentalhyperthyroidismdoesnotaffectbasalandvolumeinducedatrialnatriureticpeptidesecretioninhealthysubjects
AT dimitriospappas acuteexperimentalhyperthyroidismdoesnotaffectbasalandvolumeinducedatrialnatriureticpeptidesecretioninhealthysubjects
AT nikolaossimeonidis acuteexperimentalhyperthyroidismdoesnotaffectbasalandvolumeinducedatrialnatriureticpeptidesecretioninhealthysubjects
AT evangelosstathogiannis acuteexperimentalhyperthyroidismdoesnotaffectbasalandvolumeinducedatrialnatriureticpeptidesecretioninhealthysubjects
AT filippostriposkiadis acuteexperimentalhyperthyroidismdoesnotaffectbasalandvolumeinducedatrialnatriureticpeptidesecretioninhealthysubjects
AT georgenkoukoulis acuteexperimentalhyperthyroidismdoesnotaffectbasalandvolumeinducedatrialnatriureticpeptidesecretioninhealthysubjects
_version_ 1725715689680928768